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OBJECTIVE — To investigate the role of clinical and socioeconomic variables as determi-
nants of adherence to recommended diabetes care guidelines and assess differences in the
process of care between diabetologists and general practitioners.
RESEARCH DESIGN AND METHODS — We identiﬁed diabetic residents in Torino,
Italy, as of 31 July 2003, using multiple independent data sources. We collected data on several
laboratorytestsandspecialistmedicalexaminationsregisteredduringthesubsequent12months
and performed regression analyses to identify associations with quality-of-care indicators based
on existing guidelines.
RESULTS — After 1 year, only 35.8% of patients had undergone a comprehensive assess-
ment. In the multivariate models, factors independently and signiﬁcantly associated with lower
quality of care were age 75 years (prevalence rate ratio [PRR] 0.66 [95% CI 0.61–0.70]) and
established cardiovascular disease (0.89 [0.86–0.93]). Disease severity (PRR for insulin-treated
patients 1.45 [1.38–1.53]) and diabetologist consultation (PRR 3.34 [3.17–3.53]) were posi-
tively associated with high quality of care. No clear association emerged between sex and
socioeconomic status. These differences were strongly reduced in patients receiving diabetolo-
gist care compared with patients receiving general practitioner care only.
CONCLUSIONS — Despite widespread availability of guidelines and simple screening pro-
cedures, a nonnegligible portion of the diabetic population, namely elderly individuals and
patients with less severe forms of the disease, are not properly cared for. As practitioners in
diabetes centers are more likely to adhere to guidelines than general practitioners, quality in the
diabetes care process can be improved by increasing the intensity of disease management pro-
grams, with greater participation by general practitioners.
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D
iabetes is a major cause of morbid-
ity and mortality for millions of
people all over the world. The type
of diabetes care can greatly affect the
prognosis of patients with regards to sur-
vival (1), morbidity, and hospital usage
(2). Recall of patients and screening pro-
cesses have proved to be effective in iden-
tifying and treating patients at risk (3).
Large geographic (4), socioeconomic (5–
8),andethnic(8,9)variationsinthequal-
ity of care are present in most countries,
irrespective of the health system or eco-
nomic development (10). These inequal-
ities are inﬂuenced by a complex web of
factors, including prevalence of diabetes,
behaviors and attitudes of patients and
health care professionals, and the health
care organization.
To improve the quality of diabetes
care, surveillance systems monitoring the
process of care over geographical areas,
population subgroups, and time are
needed to allow timely identiﬁcation of
critical points and rational planning for
primary and secondary prevention of the
disease (11). In answer to this need, a
population-based surveillance program
has been implemented in the city of
Torino, Italy. The program has made it
possible to assess socioeconomic differ-
ences in the prevalence of diabetes (12)
andtheimpactofdiabetesonprescription
drug costs (13).
As a further step, we tested the feasi-
bility of generating a set of established
quality-of-careindicators(3,14–16)from
administrative databases. We report the
role of certain clinical and socioeconomic
variables as determinants of adherence to
recommended guidelines for monitoring
diabetes and assess whether the quality of
diabetes care differs between patients
cared for by a diabetologist or by other
physicians.
RESEARCH DESIGN AND
METHODS— The study base included
allresidentsinthecityofTorino(900,000
inhabitants), aged 20 years, with a di-
agnosis of diabetes, and alive as at 31 July
2003. As described in detail elsewhere
(12), patients were identiﬁed using three
datasources:theﬁleofsubjectsregistered
in the Regional Diabetes Registry (RDR),
the ﬁle of prescriptions for antidiabetes
drugs, and the ﬁle of hospital discharges
with a diagnosis of diabetes. All data
sources were matched by a deterministic
linkage procedure using a unique identi-
ﬁer and were linked to the Torino Po-
pulation Register to determine each
individual’s educational level. This was
classiﬁed according to three levels: high
(university/high school, i.e., 13 years of
education), medium (middle school, up
to 12 years of education), and low (pri-
maryschool/noformaleducation,i.e.,8
years of education). Census tract median
income data were used as a proxy of indi-
vidual income and calculated through
record linkage between the Torino Popu-
lation Register and the 1998 Tax Register
oftheMinistryofFinance.The3,419cen-
sus tracts (median number of 207 inhab-
itants) were grouped according to census
tract median income percentiles into four
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median level income €21,313), medium-
low (20th–49th percentile; €24,085),
medium-high (50th–79th percentile;
€26,604), and high (80th percentile;
€34,074) (17). We considered all those
dischargedfromahospitalintheprevious
5 years with a diagnosis of coronary heart
disease(ICD-9-CMcode410–414),cere-
brovascular disease (ICD-9-CM code
430–438), or disease of arteries (ICD-
9-CMcode440–448)asindividualswith
establishedcardiovasculardisease(CVD).
Treatment was classiﬁed into three
groups: diet only, oral antidiabetes drugs,
and insulin. Information about therapy
was retrieved from the RDR and, for pa-
tientsnotregisteredintheRDR,frompre-
scriptions of antidiabetes drugs. Subjects
who were prescribed both insulin and
oral antidiabetes drugs were assigned to
“insulin treatment”; all diabetic individu-
als who were not registered in the RDR
and had not received any antidiabetes
drug prescription (1,986 individuals)
were considered within the “diet-only
treatment” group.
The care process
All Italian citizens are cared for by a gen-
eral practitioner (1,100 in Torino) as
partoftheNationalHealthSystem(NHS).
Primarycareforindividualswithdiabetes
isprovidedmainlybyapublicnetworkof
700 diabetes clinics (14 in Torino), de-
liveringdiagnosticconﬁrmation,therapy,
help in prevention, and early diagnosis of
complications through close patient fol-
low-up by a team of specialists and the
scheduling of regular check-ups. Most
patients are referred to these care units by
their general practitioner and care is free.
All laboratory tests and specialist
medical examinations reimbursed by the
NHS in the study period were linked to
the population with diabetes to identify
thefollowingindicatorsofprocessofcare:
assessmentofA1C,serumcholesterol(to-
tal, HDL, and LDL), microalbuminuria,
examination of the eye (including at least
onefromamongocularexaminations,ob-
servationofthefundusoculi,andretinog-
raphy), and electrocardiogram (ECG)
(including either an ECG alone or exam-
inationbyacardiologist).Wealsoconsid-
ered measurements of fasting glucose and
triglycerides, but these results are not re-
portedastheyaresimilartothoseforA1C
and cholesterol. Finally, we generated a
“guidelines composite indicator” (GCI)
that included assessment of A1C and at
leasttwoassessmentsfromamongeyeex-
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microalbuminuria.
We considered all individuals who
had a diabetologic consultation at least
once in the follow-up period as cared for
by a diabetes center, whereas those who
had not were considered as cared for by a
general practitioner only. To estimate the
number of patients in the latter group
who had contact with a general practitio-
ner, they were linked to the drug pre-
scription and laboratory test databases:
99.44%hadatleastoneprescription(i.e.,
a contact with a general practitioner) in
the study period.
Statistical analysis
The study population was followed up
from 1 August 2003 to 31 July 2004. The
proportion of individuals with diabetes
receiving diabetes care procedures was
estimated using a survival analysis based
on Kaplan-Meier methods, where “sur-
vival”wasdeﬁnedastimefrombaselineto
the date of the ﬁrst laboratory test or ex-
amination. We considered as right-
censored 428 individuals who died and
100 who moved out of Torino during the
study period.
The relationship between indicators
and explicative variables was investigated
using a log-binomial regression model
and is presented as prevalence rate ratio
(PRR). The models included all the vari-
ablesdescribedaboveandthelocalhealth
unit of residence. The models were ﬁtted us-
ing PROC LIFETEST and PROC GENMOD
by SAS (version 9.1).
RESULTS— We identiﬁed 33,453 in-
dividualswithdiabetesresidinginTorino
as of 31 July 2003. The baseline charac-
teristicsareshowninTable1.After1year,
71%ofsubjectshadundergoneanassess-
ment of A1C, 65% had an assessment of
lipids,only31%hadanassessmentofmi-
croalbuminuria; 33% had undergone an
ECG, and 25% had an eye screening test.
However, only 35.8% had undergone a
more comprehensive assessment (GCI).
Sixty-eight percent of patients were seen
at least once at a diabetes center. The pro-
cess of care differed according to sociode-
mographic and clinical variables. There
were almost no differences by sex,
whereas all indicators showed large dis-
advantages among elderly individuals.
Socioeconomic differences were modest.
As for clinical variables, individuals with
established CVD had a lower frequency
for all indicators, with the exception of
ECG. The most striking difference con-
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1988 DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 care.diabetesjournals.orgcerned the treatment of diabetes, which
was strongly related to process indica-
tors; for all of the assessments consid-
ered, their frequency was lowest among
patients receiving diet-only treatment
and highest among those treated with
insulin (Table 1).
Table 2 reports the results of the mul-
tivariate models. Slight sex differences in
favor of men were present for eye exami-
nation, ECG, and GCI. The effect of age
differedbetweenmeasures;A1Candcho-
lesterolassessmentsincreasedwithageup
to the 65- to 74-year age class and de-
creased in the 75-year age-group. Mi-
croalbuminuria and eye examination
showed no difference up to the 65- to 74-
year age-group and dropped sharply in
the last age class. ECG increased with age
and only decreased slightly in the oldest
age-group. GCI showed mild differences
up to the 65- to 74-year age class and
decreased sharply in the 75-year age
class.Socioeconomicdifferenceswereab-
sent or low and, if present, favored the
disadvantagedsocialgroup.Subjectswith
previous CVD had a greater prevalence of
cardiac tests, but poorer performance for
typical diabetes screening tests, especially
GCI. The strong association between se-
verity of disease and the whole set of in-
dicators was conﬁrmed.
Table 3 shows the effect of introduc-
ingthediabetologistconsultationintothe
multivariate model of Table 2. Although
PRRs for almost all indicators remained
unchanged, differences by type of treat-
ment were considerably reduced, and the
diabetologist consultation emerged as the
strongest independent predictor of a bet-
ter screening process.
The interactions between physician
(diabetologistorgeneralpractitioner)and
nearly all the variables considered were
statisticallysigniﬁcant(P0.05).Table4
reports the results of multivariate models
in patients cared for by a diabetes center
(n  24,361) and patients cared for by
general practitioners (n  9,092). On the
whole, differences among the latter were
much greater than those among the
former, suggesting a more uniform diag-
nostic and screening approach at the sec-
ondary care level. The most striking
differences regarded the type of treat-
ment: differences between patients cared
for by a diabetologist were largely inferior
to those in patients cared for by general
practitioners.
CONCLUSIONS — The ﬁrst impor-
tant conclusion that can be drawn from
our work is that a low-cost surveillance
program to monitor the quality–of–
diabetes care process is feasible. Using
routinely collected administrative data,
we were able to monitor prospectively, at
the population level, several indicators
that are used internationally to assess the
process of care (3,14–16) and, conse-
quently, to identify some strengths and
weakness of the care system.
On the basis of this set of indicators,
the present study shows that there are
considerable opportunities for improving
the management of diabetes, particularly
in elderly patients and in those with less
severe forms of the disease. A recent sur-
vey in 100 Italian diabetes outpatient
clinics (15) reported better performance
for A1C (91.3%) and lipid measurements
Table 3—PRRs for some indicators of diabetes care process after 1 year of follow-up adjusted for diabetologist consultation
A1C Cholesterol Microalbumin Eye examination ECG GCI
Sex
Women 111111
Men 1.00 (0.99–1.01) 0.98 (0.97–1.00) 1.04 (1.01–1.07) 1.05 (1.01–1.09) 1.06 (1.03–1.10) 1.02 (0.99–1.05)
Age (years)
21–44 111111
45–54 0.99 (0.96–1.02) 1.09 (1.03–1.14) 0.96 (0.90–1.04) 0.94 (0.85–1.04) 1.41 (1.24–1.60) 1.01 (0.94–1.08)
55–64 1.02 (1.00–1.05) 1.14 (1.09–1.20) 0.99 (0.93–1.05) 0.93 (0.85–1.01) 1.67 (1.49–1.88) 1.03 (0.97–1.10)
65–74 1.04 (1.01–1.06) 1.19 (1.14–1.25) 0.89 (0.83–0.95) 0.85 (0.78–0.93) 1.78 (1.59–2.00) 0.97 (0.92–1.04)
75 1.01 (0.99–1.04) 1.03 (0.98–1.08) 0.59 (0.55–0.64) 0.58 (0.52–0.64) 1.55 (1.38–1.75) 0.66 (0.61–0.70)
Education
High 111111
Medium 1.02 (1.01–1.03) 1.01 (0.99–1.03) 0.99 (0.94–1.03) 1.07 (1.00–1.14) 1.11 (1.05–1.17) 1.01 (0.97–1.05)
Low 1.00 (0.99–1.01) 0.97 (0.95–0.99) 0.93 (0.89–0.98) 1.03 (0.97–1.10) 1.12 (1.07–1.18) 0.95 (0.91–0.99)
Income
High 111111
Medium-high 1.00 (0.99–1.02) 1.01 (0.99–1.04) 1.08 (1.02–1.14) 1.01 (0.94–1.08) 1.12 (1.06–1.18) 1.05 (1.01–1.10)
Medium-low 1.00 (0.99–1.01) 1.01 (0.99–1.03) 1.07 (1.02–1.13) 1.06 (0.99–1.13) 1.14 (1.08–1.20) 1.07 (1.02–1.12)
Low 0.99 (0.98–1.01) 0.97 (0.95–1.00) 1.03 (0.98–1.09) 1.00 (0.93–1.08) 1.12 (1.06–1.19) 0.99 (0.95–1.05)
CVD
N o 111111
Yes 0.98 (0.97–0.99) 1.02 (1.01–1.04) 0.85 (0.81–0.89) 0.90 (0.85–0.95) 1.39 (1.35–1.44) 0.89 (0.86–0.93)
Treatment
Diet only 111111
Oral drugs 1.17 (1.14–1.19) 1.09 (1.06–1.11) 1.38 (1.31–1.46) 1.41 (1.31–1.51) 1.08 (1.03–1.13) 1.37 (1.30–1.44)
Insulin 1.16 (1.14–1.19) 1.05 (1.03–1.08) 1.46 (1.38–1.55) 1.54 (1.43–1.65) 1.08 (1.03–1.13) 1.45 (1.38–1.53)
Diabetologist consult
N o 111111
Yes 2.51 (2.44–2.58) 1.86 (1.82–1.91) 3.20 (3.02–3.39) 2.42 (2.28–2.58) 2.07 (1.98–2.16) 3.34 (3.17–3.53)
Data are PRRs (95% CI). PRRs are reciprocally adjusted for all variables and for local health unit of residence.
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care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 1989(70.3%), but the same low rate of mi-
croalbuminuria tests (44.0%) was found.
RegardingsimilarityinEurope,intheEu-
ropean core indicators project (16) an-
nual A1C testing ranged from 51%
(Ireland) to 99% (France and the Nether-
lands), lipid measurements ranged from
45% (Ireland) to 99% (the Netherlands),
and microalbuminuria testing ranged
from 25% (Finland) to 97% (the Nether-
lands). However, these surveys refer ei-
ther to patients cared for by diabetes
clinics or to selected cohorts and not to
thegeneralpopulationofindividualswith
diabetes. Only a few cross-sectional stud-
iesinEuropeprovideinsightintothecare
process at the population level. In a U.K.
populationofpatientswithdiabetes,92%
had an A1C recorded within the past 15
months and 87% had a serum cholesterol
concentration recorded, whereas the test
rateformicroalbuminuriawasat39%and
retinal screening was 60% (8). Our re-
sults are very similar to those reported
in the U.S. for Medicare beneﬁciaries at
the end of the 1990s for three quality
measures: annual A1C testing, biennial
eyeexamination,andbienniallipidpro-
ﬁle (4).
These levels of care are not shared by
thewholeofthepopulationwithdiabetes,
with elderly patients being the most dis-
advantaged. The abnormal fall in the
quality of care among elderly patients,
which has also been reported in some
studies (10) but not in others (4), could
be attributable to several factors, includ-
ing greater difﬁculty in accessing health
services and competing comorbidities
that can lead to a less “aggressive” ap-
proach to the disease. On the other hand,
we found no difference in the quality of
care by socioeconomic position and only
averyslightadvantageamongmen.These
are original ﬁndings as almost all studies,
both in Europe and in the U.S., have con-
stantly shown lower quality of care and
higher risk of complications from diabe-
tesamongwomenandamongindividuals
oflowsocioeconomicstatus(5–8,10,18).
However, these ﬁndings are not unex-
pected as they are in line with previous
studies showing substantial equity in the
outcomes of care among individuals with
diabetes residing in Torino (12,19), add-
ing convincing evidence that these pa-
tients receive clinical follow-up and care
irrespectiveoftheirsocioeconomicstatus,
a fairly uncommon situation (20). The
paradoxical excess of risk in high-income
groups could be due to a more frequent
recourse to private specialists (not re-
corded in NHS administrative databases).
Regarding clinical determinants,
there is an unequivocal relationship be-
tween severity of diabetes and intensity of
care, whereas, paradoxically, a previous
cardiovascular event reduces the atten-
tiontodiabetesmonitoring.Itisplausible
that because of the presence of cardiovas-
cular complications, the interference of
another specialist, less sensitive to this is-
sue, diminishes the intensity of diabetes
screening.
However, consistently with other
studies(1,21),thestrongestpredictorand
effect modiﬁer of the quality of care is
the diabetologist. Patients cared for at a
diabetes center are more likely to be
monitored according to guidelines than
patients who are only cared for by other
physicians. Our results highlight a sever-
ity-of-disease effect, especially among pa-
tients not cared for by diabetologists. In
primary care, general practitioners are
more likely to realize the need for screen-
ing when they care for a patient taking
Table 4—PRRs for indicators of diabetes care process, by diabetologist consultation at 1 year of follow-up
A1C Cholesterol Microalbuminuria
Yes No Yes No Yes No
Sex
Women 111111
Men 1.00 (0.99–1.01) 1.02 (0.97–1.07) 0.98 (0.97–1.00) 0.98 (0.94–1.03) 1.03 (1.00–1.06) 1.10 (0.98–1.23)
Age (years)
21–44 111111
45–54 1.00 (0.97–1.03) 0.80 (0.70–0.91) 1.09 (1.04–1.15) 0.97 (0.84–1.12) 0.98 (0.91–1.06) 0.79 (0.63–0.98)
55–64 1.03 (1.00–1.05) 1.00 (0.89–1.12) 1.14 (1.08–1.19) 1.17 (1.03–1.33) 1.00 (0.93–1.08) 0.90 (0.74–1.09)
65–74 1.05 (1.02–1.07) 1.06 (0.95–1.18) 1.18 (1.12–1.23) 1.38 (1.23–1.56) 0.92 (0.85–0.98) 0.72 (0.59–0.88)
75 1.03 (1.00–1.06) 0.81 (0.72–0.91) 1.04 (0.99–1.09) 0.99 (0.87–1.12) 0.64 (0.59–0.69) 0.35 (0.28–0.43)
Educational level
High 111111
Medium 1.02 (1.01–1.04) 0.98 (0.91–1.05) 1.01 (0.98–1.03) 1.02 (0.95–1.09) 1.00 (0.96–1.06) 0.89 (0.77–1.02)
Low 1.01 (0.99–1.02) 0.93 (0.87–1.00) 0.97 (0.95–1.00) 0.94 (0.88–1.00) 0.95 (0.90–1.00) 0.89 (0.77–1.03)
Income
High 111111
Medium-high 1.00 (0.99–1.02) 1.00 (0.93–1.07) 1.02 (1.00–1.04) 0.99 (0.93–1.06) 1.11 (1.04–1.17) 0.97 (0.84–1.13)
Medium-low 1.00 (0.99–1.02) 0.98 (0.91–1.06) 1.01 (0.99–1.04) 0.99 (0.92–1.06) 1.10 (1.04–1.17) 0.90 (0.77–1.05)
Low 0.99 (0.98–1.01) 0.93 (0.85–1.01) 0.98 (0.96–1.01) 0.88 (0.82–0.96) 1.07 (1.00–1.13) 0.85 (0.71–1.01)
CVD
N o 111111
Yes 0.99 (0.97–1.00) 0.90 (0.84–0.96) 1.03 (1.01–1.05) 1.01 (0.96–1.07) 0.88 (0.84–0.92) 0.70 (0.60–0.82)
Treatment
Diet only 111111
Oral drugs 1.07 (1.05–1.09) 2.28 (2.12–2.45) 1.04 (1.02–1.07) 1.27 (1.21–1.34) 1.19 (1.12–1.25) 2.73 (2.34–3.18)
Insulin 1.06 (1.05–1.08) 2.61 (2.41–2.82) 1.02 (0.99–1.04) 1.20 (1.12–1.28) 1.23 (1.16–1.30) 3.74 (3.17–4.41)
Data are PRRs (95% CI). PRRs are reciprocally adjusted for all variables and for local health unit of residence.
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and, to a lesser extent, those taking pills
are perceived as being at lower risk or
sometimes are completely forgotten.
Treatment seems to be a reminder of the
disease and of the need for clinical assess-
ment. The severity-of-disease effect is al-
most absent among patients cared for by
diabetologists. Moreover, there is no dif-
ference by age among patients cared for
bydiabetologists,exceptfortheoldestage
class, whereas among patients who are
only cared for by general practitioners,
there is a linear inverse association with
ageandanimpressivefallinthequalityof
care among elderly patients.
Themainstrengthofourstudyisthat,
through record linkage between several
data sources, we included about 80% of
the entire population with known diabe-
tes (12) and were able to monitor the care
process longitudinally at the population
level and at very low cost. Most studies
assessing quality of care are based on ei-
ther selected populations or on more or
less large samples, a condition that makes
replication difﬁcult and costly, reduces
the feasibility of continuous monitoring
of care, and delays or invalidates timely
interventions to improve it.
Our study has several limitations that
could affect the results. Available admin-
istrative databases do not provide infor-
mation on whether risk control targets
have been met. We were only able to
monitor when laboratory tests were per-
formed but have no information about
their results. This aspect is relevant be-
cause it has been pointed out that better
process indicators do not always guaran-
teebetterintermediateoutcomes(22,23).
However, previous analysis conducted in
the same area as our study convincingly
highlighted the role of secondary care on
hard end points such as mortality (24)
andhospitaladmission(2).Asecondlim-
itation is the lack of information about
some relevant screening procedures such
as blood pressure measurement, BMI
determination, foot examination, and
duration of disease, not recorded in ad-
ministrative databases; the latter, how-
ever, should not affect adherence to
guidelines. As a proxy of disease severity
we used only insulin treatment and CVD;
thus, some residual confounding related
to diabetes complications or comorbidi-
ties can persist, and, furthermore, the ac-
curacy of our conclusions could be
affected by not accounting for physician-
level variation (both general practitioner
anddiabetologist)bymultilevelmodeling
(25); unfortunately, an identiﬁcation key
to link physicians with patients was not
available.Finally,becauseTorinoisanur-
ban area in Northern Italy and residents
have easy access to health services, we
cannot assume that our results can be
generalized to rural areas or to other
regions.
In summary, this study provides the
ﬁrst population-based data on quality in
the diabetes care process in a large south-
ern European cohort and indicates that,
despite the increasing prevalence of dia-
betes and the widespread availability of
up-to-date guidelines and screening pro-
cedures,anonnegligibleportionofthedi-
abetic population still do not receive
proper care. On the other hand, the good
news is that there are no sex or social in-
equities in health care. Diabetes centers,
although with several limitations, seem to
performscreeningregardlessofthesever-
ity of disease or other conditions. Con-
versely,patientswhoareonlycaredforby
general practitioners are at greater risk of
receiving low-quality care, as the physi-
cians may lack sufﬁcient knowledge, de-
cision support, or time to appropriately
Table 4—Continued
Eye examination ECG GCI
Yes No Yes No Yes No
111111
1.04 (1.00–1.09) 1.06 (0.95–1.19) 1.05 (1.02–1.09) 1.14 (1.05–1.24) 1.02 (099–1.04) 1.08 (0.98–1.20)
111111
1.02 (0.92–1.15) 0.61 (0.48–0.77) 1.33 (1.17–1.52) 1.79 (1.28–2.50) 1.04 (0.96–1.12) 0.74 (0.60–0.91)
0.99 (0.89–1.10) 0.71 (0.58–0.87) 1.56 (1.38–1.77) 2.33 (1.71–3.18) 1.06 (0.99–1.13) 0.86 (0.71–1.03)
0.90 (0.82–1.00) 0.71 (0.58–0.87) 1.65 (1.46–1.86) 2.65 (1.95–3.60) 1.00 (0.94–1.07) 0.79 (0.66–0.96)
0.66 (0.59–0.74) 0.30 (0.24–0.38) 1.47 (1.29–1.66) 2.06 (1.51–2.80) 0.71 (0.66–0.77) 0.33 (0.27–0.41)
111111
1.05 (0.98–1.13) 1.17 (0.99–1.37) 1.08 (1.02–1.15) 1.26 (1.10–1.44) 1.01 (0.97–1.06) 0.98 (0.86–1.12)
1.01 (0.95–1.09) 1.16 (0.98–1.36) 1.10 (1.04–1.16) 1.27 (1.11–1.44) 0.96 (0.92–1.00) 0.93 (0.81–1.07)
111111
0.99 (0.92–1.07) 1.11 (0.94–1.31) 1.11 (1.05–1.18) 1.16 (1.02–1.32) 1.07 (1.02–1.13) 0.95 (0.82–1.09)
1.06 (0.98–1.14) 1.07 (0.90–1.27) 1.14 (1.07–1.21) 1.15 (1.01–1.30) 1.09 (1.04–1.15) 0.95 (0.82–1.10)
1.01 (0.93–1.09) 0.96 (0.80–1.16) 1.13 (1.06–1.20) 1.07 (0.93–1.22) 1.02 (0.96–1.07) 0.86 (0.73–1.02)
111111
0.93 (0.88–0.99) 0.79 (0.68–0.92) 1.37 (1.33–1.43) 1.53 (1.41–1.67) 0.91 (0.88–0.95) 0.74 (0.64–0.85)
111111
1.22 (1.14–1.32) 1.97 (1.71–2.27) 1.03 (0.98–1.09) 1.21 (1.11–1.32) 1.19 (1.13–1.25) 2.80 (2.42–3.23)
1.29 (1.20–1.40) 2.75 (2.35–3.22) 1.03 (0.98–1.09) 1.20 (1.07–1.34) 1.24 (1.17–1.30) 3.68 (3.15–4.30)
Gnavi and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 1991scheduletheirpatients’annualcontrolex-
aminations. However, it must be high-
lighted that the purpose of a surveillance
system is not to rank doctors but to pro-
videevidenceforimprovement.Ourﬁnd-
ingssuggestthatcareprovidedtopatients
withdiabetescanbeimprovedbyincreas-
ing the intensity of disease management
programs to foster greater participation
by general practitioners, thus increasing
knowledgeanddecisionsupportandrais-
ing appropriateness. Moreover, an effort
to improve diabetes care in elderly pa-
tients is a priority.
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